Effectiveness and tolerability of second-line therapy with vildagliptin vs. other oral agents in type 2 diabetes: A real-life worldwide observational study (EDGE)
暂无分享，去创建一个
P. Nilsson | I. Conget | A. Penfornis | N. Schaper | A. Barnett | H. Brath | S. Wangnoo | J. J. de Castro | G. Bader | R. Göke | C. Mathieu | W. Kothny | N. Schaper | E. Pagkalos | J. Castro | E. Márquez Rodriguez | Chantal Mathieu | E. M. Rodriguez | G. Bader